 Effects HMG-CoA reductase inhibitors hypercholesterolemic patients hemodialysis efficacy lovastatin simvastatin competitive inhibitors glutaryl reductase hemodialysis HD patients hypercholesterolemia moderate hypertriglyceridemia selection patients required screening hemodialysis patients four-week placebo period lovastatin simvastatin groups patients doses period months Thirty-six patients study Lovastatin month mg months mg simvastatin month mg month mg month mg total serum cholesterol mg/dl LDL cholesterol mg/dl apolipoprotein mg/dl ratio LDL apo B/LDL cholesterol remarkable effect reduction cholesterol concentration VLDL lovastatin mg/dl simvastatin ratio triglycerides/cholesterol VLDL VLDL formation poor cholesterol rich triglycerides